"Well done folate, the little boy was born healthy without spina bifida: But will he suffer a stroke when elderly?"

European Journal of Internal Medicine

Volumn 20, Issue 1, 2009, Pages 2-

  Ntaios, George ^a   Chatzinikolaou, Anastasia ^a   Savopoulos, Christos ^a   Hatzitolios, Apostolos ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; HOMOCYSTEINE; VITAMIN B GROUP;

CARDIOVASCULAR RISK; EDITORIAL; HEART INFARCTION; HUMAN; SPINA BIFIDA; STROKE; VITAMIN SUPPLEMENTATION;

AGED; FOLIC ACID; HUMANS; INFANT, NEWBORN; MALE; RISK FACTORS; SPINAL DYSRAPHISM; STROKE;

EID: 60449112684     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2008.03.015     Document Type: Editorial

References (6)

1. CDC. Spina bifida and anencephaly before and after folic acid mandate: United States, 1995-1996 and 1999-2000. MMWR Morb Mortal Wkly Rep 53 (2004) 362-365
2. Bayston R., Russell A., Wald N.J., and Hoffbrand A.V. Folic acid fortification and cancer risk. Lancet 370 9604 (2007) 2004
3. Ntaios G.C., Savopoulos C.G., Chatzinikolaou A.C., Kaiafa G.D., and Hatzitolios A. Vitamins and stroke: the homocysteine hypothesis still in doubt. Neurologist 14 1 (2008) 2-4
4. Wang X., Qin X., Demirtas H., Li J., Mao G., Huo Y., Sun N., Liu L., and Xu X. Efficacy of folic acid supplementation in stroke prevention: a meta-analysis. Lancet 369 9576 (2007) 1876-1882
5. B-Vitamin Treatment Trialists' Collaboration. Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials. Am Heart J 151 (2006) 282-287
6. Lonn E. Homocysteine in the prevention of ischemic heart disease, stroke and venous thromboembolism: therapeutic target or just another distraction?. Curr Opin Hematol 14 5 (2007) 481-487